Further studies are needed to establish recommendations for GLP-1 RA medication use in treating gynecologic conditions
The triple therapy of metformin, a DPP-4 inhibitor and a SGLT-2 inhibitor has a very low treatment related hypoglycaemia risk, leads to a further, almost additive reduction of glycaemic parameters, a body weight loss in the same range as with a mono- or dual therapy with a SGLT-2 inhibitor and also to the expected SGLT-2 inhibitor induced reduction of blood pressure
Transcriptomic profiling identifies CD8 + T cells in the brain of aged and Alzheimers disease transgenic mice as tissue-resident memory T cells
Think of moderating alcohol as giving your liver, the body's primary filtration system, a much-needed break
People often ask how fast weight loss happens
If treatment is recommended, a clinician evaluation and valid prescription are required